EODData

FRA, 214: ANEBULO PHARMAC. DL-001

02 Sep 2025
LAST:

1.530

CHANGE:
 0.00
OPEN:
1.530
HIGH:
1.530
ASK:
0.000
VOLUME:
0
CHG(%):
0.00
PREV:
1.530
LOW:
1.530
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Sep 251.5301.5301.5301.5300
01 Sep 251.5301.5301.5301.5300
29 Aug 251.5301.5301.5301.5300
28 Aug 251.5301.5301.5301.5300
27 Aug 251.5301.5301.5301.5300
26 Aug 251.5301.5301.5301.5300
25 Aug 251.5301.5301.5301.5300
22 Aug 251.5301.5301.5301.5300
21 Aug 251.5301.5301.5301.5300
20 Aug 251.5301.5301.5301.5300

COMPANY PROFILE

Name:ANEBULO PHARMAC. DL-001
About:Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.
Sector:Healthcare
Industry:Biotechnology
Address:1017 Ranch Road 620 South, Lakeway, TX, United States, 78734
Website:https://www.anebulo.com
ISIN:US0345691036

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:1.53
MA10:1.53
MA20:1.53
MA50:1.45
MA100:1.20
MA200:1.23
Week High:1.53
Week Low:1.53
Month High:1.53
Month Low:1.52
Year High:2.02
Year Low:0.72